Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference. - Wikidata - wikimedia - TriplyDB

Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

http://www.wikidata.org/entity/Q37362850

about

Nucleot(s)ide analogues for hepatitis B virus-related hepatocellular carcinoma after curative treatment: a systematic review and meta-analysis Immune therapy for hepatitis B Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.KIR and HLA loci are associated with hepatocellular carcinoma development in patients with hepatitis B virus infection: a case-control study Cirrhosis and its complications: evidence based treatment.De novo acute hepatitis B in myeloperoxidase-specific anti-neutrophil cytoplasmic autoantibody-related microscopic polyangiitis treated with corticosteroids.Efficient inhibition of hepatitis B virus replication by hepatitis delta virus ribozymes delivered by targeting retrovirus.Efficacy and tolerability of lamivudine in hepatitis B infected renal transplant recipients: A single center study.Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B.Systematic review of the literature on comparative effectiveness of antiviral treatments for chronic hepatitis B infection.Long-term nucleos(t)ide analogues therapy for adults with chronic hepatitis B reduces the risk of long-term complications: a meta-analysis Designing immune therapy for chronic hepatitis B.Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model.Evidence-based clinical guidelines for immigrants and refugees.KASL Clinical Practice Guidelines: Management of chronic hepatitis B.Adenine: an important drug scaffold for the design of antiviral agents HD-03/ES: A Herbal Medicine Inhibits Hepatitis B Surface Antigen Secretion in Transfected Human Hepatocarcinoma PLC/PRF/5 Cells Antiviral therapy for prevention of hepatocellular carcinoma and mortality in chronic hepatitis B: systematic review and meta-analysis National Institutes of Health consensus development conference statement: management of hepatitis B.Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries.Endpoints of hepatitis B treatment.Future aspects of therapy for hepatitis B virus infection: value of surrogate markers, innovative therapy, and global collaboration.Role of molecular diagnostics in the management of viral hepatitis B.Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.Antiviral therapy after curative treatment of hepatitis B/C virus-related hepatocellular carcinoma: A systematic review of randomized trials.Hepatic Resection Improved the Long-Term Survival of Patients with BCLC Stage B Hepatocellular Carcinoma in Asia: a Systematic Review and Meta-Analysis.Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries.Novel insights into immunotherapy for hepatitis B patients.Synthesis and Quantitative Structure-activity Relationships Study for Arylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication.Complexity and uncertainty of living with an invisible virus of hepatitis B in Korea.Therapeutic potential of a combined hepatitis B virus surface and core antigen vaccine in patients with chronic hepatitis B.Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B.Antiviral therapy for chronic hepatitis B virus infection and development of hepatocellular carcinoma in a US population.A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection.The effect of antiviral therapy on patients with hepatitis B virus-related hepatocellular carcinoma after curative resection: a systematic review and meta-analysis.Genetic diversity of hepatitis B virus genotypes B6, D and F among circumpolar indigenous individuals.Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.Immunosuppressive functions of hepatic myeloid-derived suppressor cells of normal mice and in a murine model of chronic hepatitis B virus.Surrogate end-points for treatment trials of hepatitis B virus.

P2860

Q26998178-E0D3EEC1-1906-42C3-A54E-F8D2A8092EC1 Q28078856-E84BC2E1-7C3E-40F6-BFC7-6536279F118C Q30829485-15CC968F-0AD5-4D36-9DA6-73B54B39F741 Q31037177-69E80182-C5A4-4030-8F71-8A836A92813C Q33594931-1C561F86-8D55-455B-AF52-E8A177A50909 Q33628268-6F8DCC10-89E6-4671-81F4-59852C7329AD Q33774434-4DB3615C-3031-42B2-831E-A52787864100 Q33809854-748FD0BF-1D30-4782-9EF9-F9CF72FF644B Q34391578-5EBA9280-2BE3-4727-A964-12C6F11AB9D2 Q34594403-799ACBE0-AB45-40EA-8861-DD41148AC932 Q34615975-1F7B6A46-4C83-4B3F-B4AD-14D15152A869 Q34825732-9D87BD56-6E25-4969-9123-08CEACC4B39E Q34998414-C0C31ABE-96A5-4145-A69D-9F20AE1D3564 Q35102779-190CD14E-906D-4189-B080-60B2BE1BB597 Q35201293-44256BD0-C204-4764-A6DA-CE4BAA552B24 Q36153966-D6B4CA42-A797-495C-B8D1-53C022AC8297 Q36238668-55708C70-B9A9-4046-A347-2DA5E51D1923 Q36804820-3573DD80-ABED-4862-8B0D-2F6EFD315551 Q37117293-2F0B0DE8-7D8D-4D3F-821E-BEDCB398931D Q37462573-783F0555-E57F-4523-8207-AB66590BB9C0 Q37508051-CCEB2092-71AF-44B6-890A-4E4FC17E942B Q37788776-C914B46A-D458-49A5-A133-1D7492D85A4B Q37869826-A682866D-0EDD-4A56-852C-7DA8BFFC9CCA Q38088408-68A7B974-B718-4E98-90D0-00930BA9AE77 Q38098583-8A670F51-633F-45F3-A7FF-A980EF8A4313 Q38100807-79170E2F-802C-4F13-8B9F-8EB4299E8E0E Q38460881-BFFFA648-30E7-4615-A005-F441E1532E11 Q38552485-7025D8DE-C0E8-4661-816E-2BA921123152 Q38655228-926B9F15-F5B1-4FC1-B156-0F3552B89A8C Q39845532-06D0D386-2673-4D64-8F5E-5F66FCC3B99E Q39921434-A4C8A752-A5BF-4FC0-94E2-85D59C7C86BF Q40706767-C1903526-03E1-48BE-AA87-177E886FBB58 Q42228903-91407D4A-1812-44BA-836C-F3EFF4962F69 Q42263840-199A8C90-AB22-4741-A819-796A6186F8E0 Q43281548-9B027E9F-AE30-45C8-A032-F9E38B4C022F Q45324177-306CA8CA-E212-419A-A50A-8AB989C76924 Q45353145-AA19C086-B0E7-4352-9F26-372CBE02D1BD Q45360538-557A4730-CDBD-44D5-A6CD-287DB8D716D5 Q45364959-BAD3A5D7-ADF3-4E71-9030-8934AA81CB25 Q45374922-222185CD-EE9B-4693-917D-5BE025426D57

P2860

Antiviral therapy for adults with chronic hepatitis B: a systematic review for a National Institutes of Health Consensus Development Conference.

http://www.wikidata.org/entity/Q37362850

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 05 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antiviral therapy for adults w ...... sensus Development Conference.

@en

Antiviral therapy for adults w ...... sensus Development Conference.

@nl

type

label

Antiviral therapy for adults w ...... sensus Development Conference.

@en

Antiviral therapy for adults w ...... sensus Development Conference.

@nl

prefLabel

Antiviral therapy for adults w ...... sensus Development Conference.

@en

Antiviral therapy for adults w ...... sensus Development Conference.

@nl

P1433

Q37362850-3D46146F-D763-432A-9A5B-684EBFBF9209

P1476

Q37362850-3132410A-B371-495D-BEE0-9D16357AB5F6

P2093

Q37362850-0BC58F47-E897-4EFF-A22F-938D21B9BD2E

Q37362850-140F704D-74DE-4EAB-BEB3-83C2CD26A8A1

Q37362850-221591F5-7B29-415B-BA9B-D6E3E1E0AD2F

Q37362850-22EDE6AF-EC20-4267-A3EF-A86BA7370C52

Q37362850-303C0D49-B8BB-4DE3-9E80-0E37911E16AB

Q37362850-66565FCD-672E-4EE8-BB5B-C33DA3C58425

Q37362850-B5BF8E9C-B4CD-4FF4-A990-82B38DD38314

Q37362850-E18007C0-A193-4954-90F4-82ACDBD5D72A

P304

Q37362850-0774BE8C-BC31-49EC-A26B-D566A440CCA5

P31

Q37362850-7CC991CB-2BBE-4EC1-B3DC-C4771A685B1D

P356

Q37362850-7BF2F4C5-FBD8-4D27-B76B-76A9D76CB2F8

P407

Q37362850-8CD3BAAB-EF79-471C-8E67-A434C49B054A

P433

Q37362850-9A98E834-B30D-468C-8C66-04A613C8EAB0

P478

Q37362850-0F05D592-DC31-4101-97F1-E6DC2885F9B7

P50

Q37362850-3D423369-2525-492C-8A6A-00C7649165E6

Q37362850-9BFB1D2F-C526-4B92-A079-73A6C6CDA529

P577

Q37362850-EF9ADEC7-E48C-42C5-A716-E09290F29631

P5875

Q37362850-260BECF5-BD95-4587-AB35-21F27D4A8C43

P698

Q37362850-A73B6600-4838-4619-A191-1964A2A9291A

P356

0003-4819-150-2-200901200-00101

P1433

Annals of Internal Medicine

P1476

Antiviral therapy for adults w ...... sensus Development Conference.

@en

P2093

Aasma Shaukat

http://www.w3.org/2001/XMLSchema#string

Indulis Rutks

http://www.w3.org/2001/XMLSchema#string

James Tacklind

http://www.w3.org/2001/XMLSchema#string

Jian-Min Yuan

http://www.w3.org/2001/XMLSchema#string

Robert L Kane

http://www.w3.org/2001/XMLSchema#string

Roderick MacDonald

http://www.w3.org/2001/XMLSchema#string

Tatyana A Shamliyan

http://www.w3.org/2001/XMLSchema#string

Timothy J Wilt

http://www.w3.org/2001/XMLSchema#string

P304

111-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-150-2-200901200-00101

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

150

http://www.w3.org/2001/XMLSchema#string

P50

Brent C. Taylor

James R Johnson

P577

2009-01-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273997295

http://www.w3.org/2001/XMLSchema#string

P698

19124812

http://www.w3.org/2001/XMLSchema#string